Related Experiment Videos
Sexually transmitted diseases in postpubertal female rape victims
J B Glaser1, J Schachter, S Benes
1Department of Medicine, State University of New York (SUNY) Health Science Center, Brooklyn 11203.
The Journal of Infectious Diseases
|October 1, 1991
Summary
Sexual assault survivors face significant risks of sexually transmitted infections like Chlamydia trachomatis, bacterial vaginosis, and trichomoniasis. Immediate treatment is recommended due to high infection rates and poor follow-up compliance.
Area of Science:
- Infectious Diseases
- Public Health
- Forensic Medicine
Background:
- Sexual assault is a critical public health issue with potential for infectious sequelae.
- Timely evaluation of sexual assault victims is crucial for managing health risks, including sexually transmitted infections (STIs).
Purpose of the Study:
- To determine the prevalence of active infections and the risk of acquiring Chlamydia trachomatis following sexual assault.
- To assess the incidence of pelvic inflammatory disease, bacterial vaginosis, and trichomoniasis in sexual assault survivors.
- To recommend evidence-based treatment protocols for post-assault infections.
Main Methods:
- Seventy-six postpubertal women presenting within 60 hours of sexual assault were evaluated.
- Diagnostic methods included C. trachomatis culture, serologic titer testing, and clinical diagnosis for bacterial vaginosis and trichomoniasis.
- Follow-up compliance rates were recorded.
Main Results:
- Twenty-six percent of victims had active Chlamydia trachomatis infection.
- The estimated risk of acquiring C. trachomatis infection ranged from 3% to 16%.
- Pelvic inflammatory disease was diagnosed in 11% of victims, bacterial vaginosis in 50%, and trichomoniasis in 22%.
Conclusions:
- Sexual assault is associated with a high incidence of C. trachomatis, bacterial vaginosis, and trichomoniasis.
- Given high infection rates and suboptimal follow-up, empirical treatment is warranted.
- Recommended treatment includes ceftriaxone, doxycycline, and metronidazole for all postpubertal sexual assault victims.